BeKey

Home
Israel
Ashdod
BeKey

BeKey is focused on creating and operating cost effective and flexible, dedicated teams for small and large businesses.

05/11/2026

What is your healthcare AI agent allowed to do after it gets access?

In an Imprivata-commissioned survey of 250 U.S. healthcare leaders, 72% reported that AI tools or agents were deployed without formal IT approval at least occasionally.

That finding raises a practical question for teams building healthcare AI: can customers demonstrate both measurable value and control over what the system does?

An agent might summarize a referral, draft a patient message, or update a record. Each action carries different responsibilities—and needs clear boundaries.

In the first edition of Digital Health Signal, we explore:
→ how to measure value across the complete workflow
→ where permissions and human approval need to be enforced
→ what teams should be able to trace, stop, and reassess before scaling

For healthcare product teams, these decisions belong in the development plan from the start.

Read the full article on the BeKey blog: https://bekey.io/blog/healthcare-ai-agents-need-to-prove-two-things-value-and-control

Healthcare AI agents need to demonstrate measurable value and operational control. Explore what product teams should check before scaling AI in real workflows.

29/10/2026

More software does not always mean less work in healthcare operations.

Many teams already use an EHR, CRM, support platform, billing tool, scheduling system, spreadsheets, dashboards, and messaging apps. But if these tools do not support the workflow end to end, staff still spend hours checking systems, copying information, confirming status, and coordinating handoffs manually.

That is healthcare tool sprawl.

Our new article explains why disconnected healthcare tools create hidden manual work, why integration is better than adding another platform, and how operations leaders can understand whether their stack is ready for automation.

Read the full article:

Healthcare tool sprawl happens when software solves individual tasks but fails to support workflows end to end. Learn how disconnected healthcare tools create manual work and when integration can help.

27/10/2026

The cheapest AI tool can look like the safest choice at first.

A low subscription price makes it easy to approve, easy to test, and easy to add to the stack. But the real cost often appears later: manual workarounds, missing integrations, unclear review steps, compliance gaps, retraining, migration, and tool sprawl.

That is where AI tool hidden costs start to matter.

Our new article explains why founders, COOs, finance leaders, and product teams should evaluate the full workflow cost of an AI tool before adding it to their stack,not just the monthly price.

Read the full article:

AI tool hidden costs can make a cheap solution expensive through manual workarounds, missing integrations, review gaps, compliance needs, migration, retraining, and tool sprawl.

21/10/2026

The cheapest AI tool is not always the cheapest option once the full workflow is counted.

A low monthly price can look safe at first. But after implementation, teams may still deal with manual workarounds, disconnected systems, missing integrations, review steps, compliance gaps, retraining, migration, and tool sprawl.

That is where AI tool hidden costs start to show up.

Our new article explains why founders, COOs, finance leaders, and product teams should evaluate the real cost of an AI tool before adding it to the stack, not just the subscription price, but the workflow it leaves behind.

Read the full article: https://bekey.io/blog/why-the-cheapest-ai-tool-can-become-the-most-expensive-choice

AI tool hidden costs can turn a cheap solution into an expensive one through manual workarounds, integrations, review gaps, compliance needs, migration, and tool sprawl.

19/10/2026

AI budget planning should not start with tools. It should start with workflows.

As companies plan next year’s budget, many teams are already asking where AI can reduce manual work, improve speed, or support operations. But not every AI idea deserves funding, and not every promising pilot is ready for a larger investment.

The strongest AI automation budgets are built around workflows with measurable manual effort, clear business impact, realistic feasibility, and manageable risk.

Our new article explains how executives, founders, COOs, and CFOs can prioritize AI automation projects before next year — from estimating ROI and hidden costs to choosing which workflows should be built, bought, integrated, or customized.

Read the full article: AI Automation Budget Planning: https://bekey.io/blog/ai-automation-budget-planning-how-to-prioritize-workflows-before-next-year

AI automation budget planning helps companies prioritize workflows before next year by assessing manual effort, business impact, ROI, hidden costs, feasibility, and risk.

13/10/2026

A patient visit can involve a lot of switching between screens: checking records, reviewing results, writing notes.

In our new video, we look at how ambient AI could help clinicians spend less time navigating software and more time with patients. We also touch on what still needs to happen behind the scenes, from security to human review.

Watch “Healthcare Without Interfaces: The Future of Ambient Systems” here: https://www.youtube.com/watch?v=aPCQQMSfiow

What if the future of healthcare meant fewer screens, fewer clicks,...

01/10/2026

Human-in-the-loop AI is not just a safety principle. It is a workflow design decision.

In regulated or compliance-heavy operations, AI can summarize, classify, draft, route, and prepare work. But teams still need to define where humans should approve, decide, validate, or escalate.

If review is added only after implementation, the workflow may already be too unclear: no owner, no approval step, no escalation path, and no practical way to monitor outcomes.

Our new article explains where human review should stay in AI workflows and how teams can decide which outputs should be automated, reviewed, or escalated.

Read the full article:

Human-in-the-loop AI helps teams decide which AI outputs can be automated, which need human review, and which should be escalated in regulated or compliance-heavy workflows.

30/09/2026

AI governance should not appear only after a company starts scaling AI.

In healthcare and other regulated operations, governance needs to be part of the workflow design from the beginning. Leaders need to define what data AI can access, who owns decisions, which outputs require human review, what should be escalated, and how performance will be monitored after launch.

Without those rules, AI can create more risk than efficiency.

Our new article explains what executives, compliance leaders, COOs, and CTOs should define before scaling AI across regulated workflows.

Read the full article:

AI governance for healthcare and regulated operations helps leaders define data access, human review, audit trails, monitoring, ownership, and escalation rules before scaling AI.

25/09/2026

A working AI pilot is not the same as production readiness.

A pilot can look strong in a controlled setting: selected inputs, a small user group, limited edge cases, and no heavy integration requirements. But once AI moves into real operations, the expectations change.

It needs to handle imperfect data, unclear requests, human review, workflow ownership, system integrations, security requirements, and measurable business outcomes.

Our new article breaks down 5 signs your AI pilot is not ready for production yet and what teams should fix before scaling.

Read the full article:

Learn 5 signs your AI pilot is not ready for production, from perfect-input testing and unclear ownership to missing review logic, weak integrations, and no success metrics.

23/09/2026

AI experiments are useful, but they are not the same as operational systems.

A pilot can work with a small data sample, a few users, limited edge cases, and minimal integration. But production AI needs more: clear workflows, usable data, system connections, governance, human review, ownership, and measurable outcomes.

That is why companies need an AI implementation roadmap before moving from experiment to production.

Our new article explains how executives, founders, CTOs, and COOs can move beyond pilot mode and turn AI experiments into operational systems that teams can actually use, trust, and improve.

Read the full article:

An AI implementation roadmap helps companies move from experiments and pilots to operational AI systems with clear workflows, integrations, governance, human review, and measurable value.

Address

Ashdod
77716

Website

http://bekey.io/

Alerts

Be the first to know and let us send you an email when BeKey posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.